Search research articles
Contact Us
Filters
Showing results (31-40 of 90) with videos related to
Page
of 9
Sort By:
Critical Reviews in Oncology/Hematology
|
January 1, 1990
Cisplatin rescue therapy: experience with sodium thiosulfate, WR2721, and diethyldithiocarbamate
D R Gandara, V J Wiebe, E A Perez, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 1, 1993
Delayed emesis following high-dose cisplatin: a double-blind randomised comparative trial of ondansetron (GR 38032F) versus placebo
D R Gandara, W H Harvey, G G Monaghan, et al.
Annals of Internal Medicine
|
January 1, 1988
Renal salt wasting in patients treated with cisplatin
F N Hutchison, E A Perez, D R Gandara, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
June 18, 1998
Consensus proposal for 5HT3 antagonists in the prevention of acute emesis related to highly emetogenic chemotherapy. Dose, schedule, and route of administration
D R Gandara, F Roila, D Warr, et al.
Investigational New Drugs
|
December 16, 1998
Phase II trial of oral beta-all trans-retinoic acid in hepatocellular carcinoma (SWOG 9157)
F L Meyskens, J Jacobson, B Nguyen, et al.
Cancer
|
July 10, 2001
Sequential combination chemotherapy in patients with advanced nonsmall cell lung carcinoma: carboplatin and gemcitabine followed by paclitaxel
M J Edelman, D R Gandara, D H Lau, et al.
Cancer Chemotherapy and Pharmacology
|
January 1, 1989
Topical dimethylsulfoxide may prevent tissue damage from anthracycline extravasation
H J Lawrence, D Walsh, K A Zapotowski, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
January 29, 2000
Control of high-dose-cisplatin-induced emesis with an all-oral three-drug antiemetic regimen
P J Hesketh, A Roman, A M Hesketh, et al.
Journal of Immunotherapy : Official Journal of the Society for Biological Therapy
|
February 1, 1991
Weekly 24-hour continuous infusion interleukin-2 for metastatic melanoma and renal cell carcinoma: a phase I study
E A Perez, S A Scudder, F A Meyers, et al.
Seminars in Oncology
|
August 1, 1997
Twice-weekly paclitaxel and radiation for stage III non-small cell lung cancer
D H Lau, J K Ryu, D R Gandara, et al.
Page
of 9
Search research articles
Search
Showing results (31-40 of 90) with videos related to
Sort By:
Page
of 9
Critical Reviews in Oncology/Hematology
|
January 1, 1990
Cisplatin rescue therapy: experience with sodium thiosulfate, WR2721, and diethyldithiocarbamate
D R Gandara, V J Wiebe, E A Perez, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 1, 1993
Delayed emesis following high-dose cisplatin: a double-blind randomised comparative trial of ondansetron (GR 38032F) versus placebo
D R Gandara, W H Harvey, G G Monaghan, et al.
Annals of Internal Medicine
|
January 1, 1988
Renal salt wasting in patients treated with cisplatin
F N Hutchison, E A Perez, D R Gandara, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
June 18, 1998
Consensus proposal for 5HT3 antagonists in the prevention of acute emesis related to highly emetogenic chemotherapy. Dose, schedule, and route of administration
D R Gandara, F Roila, D Warr, et al.
Investigational New Drugs
|
December 16, 1998
Phase II trial of oral beta-all trans-retinoic acid in hepatocellular carcinoma (SWOG 9157)
F L Meyskens, J Jacobson, B Nguyen, et al.
Cancer
|
July 10, 2001
Sequential combination chemotherapy in patients with advanced nonsmall cell lung carcinoma: carboplatin and gemcitabine followed by paclitaxel
M J Edelman, D R Gandara, D H Lau, et al.
Cancer Chemotherapy and Pharmacology
|
January 1, 1989
Topical dimethylsulfoxide may prevent tissue damage from anthracycline extravasation
H J Lawrence, D Walsh, K A Zapotowski, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
January 29, 2000
Control of high-dose-cisplatin-induced emesis with an all-oral three-drug antiemetic regimen
P J Hesketh, A Roman, A M Hesketh, et al.
Journal of Immunotherapy : Official Journal of the Society for Biological Therapy
|
February 1, 1991
Weekly 24-hour continuous infusion interleukin-2 for metastatic melanoma and renal cell carcinoma: a phase I study
E A Perez, S A Scudder, F A Meyers, et al.
Seminars in Oncology
|
August 1, 1997
Twice-weekly paclitaxel and radiation for stage III non-small cell lung cancer
D H Lau, J K Ryu, D R Gandara, et al.
Page
of 9